Carbapenem-resistant Enterobacterales bacteraemia at a tertiary hospital: A five-year review. [PDF]
Marais D +3 more
europepmc +1 more source
Susceptibility to novel antimicrobial agents and molecular epidemiology of carbapenem-resistant enterobacterales: a 9-year study in Central China. [PDF]
Han Y +12 more
europepmc +1 more source
Background: Carbapenem-resistant Enterobacterales (CRE) are an emerging global public health threat associated with multidrug resistance, prolonged hospitalization, increased healthcare costs, and elevated mortality. Early identification of carbapenemase
Murugan, Harinee +2 more
core
The pharmacokinetics/pharmacodynamics index of high-dose tigecycline in patients with carbapenem-resistant Enterobacterales bloodstream infection: a prospective study. [PDF]
Somsirikarnjanakoon S +4 more
europepmc +1 more source
Progress in the Treatment of Carbapenem-Resistant Enterobacterales Infections
openaire +1 more source
<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]
Yanagihara K +7 more
europepmc +1 more source
Risk factors associated with carbapenem-resistant Enterobacterales infections in hospitalized patients: A case-control study. [PDF]
Zambrano-Calderero V +2 more
europepmc +1 more source
Prevalence, trend and resistance patterns of carbapenem-resistant Enterobacterales in Bangladesh: a nationwide laboratory-based study. [PDF]
Rahman A +12 more
europepmc +1 more source
Risk-Based Pre-Admission Screening for Carbapenem-Resistant Enterobacterales (CRE): A Patient-Level Observational Study in a High-Endemic European Setting. [PDF]
Altavilla S +5 more
europepmc +1 more source

